Smith & Nephew plc (ETR:NPW1)

Germany flag Germany · Delayed Price · Currency is EUR
15.53
+0.04 (0.26%)
At close: Feb 26, 2026
-4.67%
Market Cap 13.28B
Revenue (ttm) 5.07B
Net Income (ttm) 419.07M
Shares Out n/a
EPS (ttm) 0.48
PE Ratio 31.68
Forward PE 16.77
Dividend 0.13 (0.83%)
Ex-Dividend Date Oct 2, 2025
Volume n/a
Average Volume 235
Open 15.53
Previous Close 15.49
Day's Range 15.53 - 15.53
52-Week Range 13.66 - 16.57
Beta n/a
RSI 67.59
Earnings Date Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1856
Employees 17,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol NPW1
Full Company Profile

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD Financial Statements

News

There is no news available yet.